If you operate an Article 31 outpatient mental health clinic in New York — formally called an MHOTRS program (Mental Health Outpatient Treatment and Rehabilitative Services) since 2022 — 2026 is the most active year for behavioral health M&A in over a decade.
The numbers tell the story. Behavioral health acquisitions grew from 32 facilities in 2010 to 1,330 in 2021. Private-equity-backed deals account for roughly 60% of all transactions. Sector deal volume rose 47.1% year-over-year through Q3 2025. Median EBITDA multiples for behavioral health platforms sit at 8–12x in 2026 — the highest of any healthcare service category.
Translation: if you've built an Article 31 clinic in NY and you're contemplating an exit, you have leverage you didn't have three years ago.
This guide covers what NY Article 31 / MHOTRS clinic operators need to know in 2026 — valuation, the OMH license transfer process, the difference between a corporate buyer and a strategic buyer, and how to structure a deal that protects your patients and your team.
What is an Article 31 / MHOTRS clinic?
Article 31 of New York Mental Hygiene Law authorizes the New York State Office of Mental Health (OMH) to license outpatient mental health programs. The official program name was rebranded from "Article 31 Clinic" to "MHOTRS" (Mental Health Outpatient Treatment and Rehabilitative Services) in late 2022 under the updated 14 NYCRR Part 599 regulations.
Common Article 31 / MHOTRS service types:
- Outpatient psychiatry and psychotherapy
- Medication management
- Crisis services and Comprehensive Psychiatric Emergency Programs (CPEP)
- Assertive Community Treatment (ACT) team programs
- Continuing day treatment and personalized recovery-oriented services (PROS)
- Family and group therapy
- Co-occurring disorder treatment (with OASAS dual licensure)
Most Article 31 clinics bill Medicaid under the Ambulatory Patient Group (APG) rate methodology, which generally produces stronger reimbursement than commercial behavioral health rates.
Why behavioral health M&A is so hot in 2026
Three structural drivers:
1. Demand outstrips supply. Mental health utilization in NY has doubled since 2019. Reimbursement rates have improved. Wait times at most clinics are 6–12 weeks for new patients. There is no scenario in the next decade where this demand softens — but supply expansion is constrained by NY's licensure regime.
2. PE consolidation thesis works in behavioral health. Behavioral health businesses have:
- High margins (15–25% EBITDA in well-run clinics)
- Recurring patient revenue (low patient churn)
- Fragmented ownership (most operators are single-clinic or small chains)
- Clear consolidation upside (centralized billing, technology, recruiting)
This is the textbook PE roll-up profile. Of the 60% of behavioral health deals backed by PE, almost all are consolidation plays.
3. Article 31 license scarcity. OMH has not been issuing new MHOTRS licenses at a pace anywhere close to demand. Acquiring an existing license is faster than starting a new one. Buyers will pay a premium for licensed capacity.
What is your Article 31 clinic worth in 2026?
Multiples for a 2–4 site Article 31 / MHOTRS platform in NY metro typically:
- Single-site MHOTRS clinic, $3–7M revenue: 5–8x EBITDA
- 2–4 site behavioral health platform, $7–14M revenue: 8–11x EBITDA
- Larger platforms (5+ sites, $15M+ revenue): 10–12x EBITDA
- Specialty behavioral health (ACT, ADHD, eating disorders): 9–12x EBITDA
Real-world example: a 3-site MHOTRS clinic in Queens with $10M of revenue and $1.8M of EBITDA could reasonably trade for $14–20M (8–11x) in 2026. That same platform would have traded for $9–12M (5–7x) in 2019.
Multiple expanders and compressors specific to Article 31
Multiple expanders:
- In-network with all 5 major NY Medicaid managed care plans (Healthfirst, Fidelis, MetroPlus, EmblemHealth, Empire BCBS)
- Specialty service lines (ACT teams, child/adolescent specialty, dual-diagnosis with Article 32 OASAS)
- High clinician retention (>80% retention year-over-year)
- Telehealth integration with reimbursement parity locked in
- Strong intake-to-first-appointment time (<14 days)
- Existing CCBHC certification (Certified Community Behavioral Health Clinic) or CCBHC pipeline status
Multiple compressors:
- Recent OMH survey deficiencies (any unresolved corrective action plan)
- Single-payor concentration above 50% Medicaid fee-for-service
- High clinician turnover
- Owner-clinician dependency (if 30%+ of revenue is from one owner-clinician, the practice transfers poorly)
- Outdated EHR (homegrown systems, paper records)
The OMH license transfer process
Selling an Article 31 / MHOTRS clinic isn't like selling a private practice. The OMH operating certificate is the asset, and OMH approves the license transfer.
Three regulatory tracks must run in parallel:
Track 1: OMH operating certificate transfer
The buyer entity must obtain an OMH operating certificate, either by transfer of the existing license (most common) or by co-licensure (during transition). OMH reviews:
- Character & competence of every 10%+ owner of the buyer entity
- Programmatic capacity — does the buyer have the operational systems to run the clinic well?
- Clinical leadership credentials — who will be the program director, medical director?
- Continuity of services to existing patients
OMH approval typically takes 4–7 months. Buyers prefer to file early and have the approval in hand before close.
Track 2: Material Transaction Notice (PHL Article 45-A)
If the deal increases in-state revenue by $25M or more, a 30-day prior notice must be filed with NY DOH using the electronic Material Transactions Reporting Form. The filing is publicly posted for comment. This is the same filing used for Article 28 transactions.
Track 3: Medicaid managed-care reassignment
Each Medicaid managed-care contract must be assigned or re-executed for the new operator. Healthfirst, Fidelis, MetroPlus, EmblemHealth, and Empire BCBS each have their own credentialing timelines (typically 60–120 days).
Total close timeline from LOI: typically 6–10 months for behavioral health (faster than Article 28 because OMH processes are usually quicker than PHHPC).
Buyer types — corporate, strategic, or PE platform?
Article 31 buyers fall into three buckets, each with very different deal economics:
Corporate / nonprofit acquirer (~25% of buyers): Existing Article 31 nonprofit operator looking to expand footprint. They pay market multiples but offer the strongest continuity for staff and patients. Examples: ICL, The Bridge, F.E.G.S., Vibrant Emotional Health.
Strategic acquirer (~20%): Hospital systems or larger healthcare platforms acquiring Article 31 capacity to integrate with existing service lines. They pay strategic premiums (1–2 turns above PE multiples) but require the most operational integration.
PE-backed platform (~55%): Healthcare-specialist private equity buying Article 31 platforms as part of a national or regional roll-up strategy. They pay premium multiples (8–12x EBITDA), prefer 12–24 month seller transition agreements, and value continuity but often consolidate back-office functions post-close.
A good buy-side or sell-side broker will know which of these three buyers is the best fit for your specific clinic and your specific exit goals.
Why nonprofit ownership doesn't preclude a sale
Many Article 31 / MHOTRS clinics are operated by 501(c)(3) nonprofits. Common misconception: "nonprofits can't be sold."
Wrong. Nonprofits can be:
- Acquired through asset sales (the buyer purchases the clinic's assets, including the license, and the selling nonprofit dissolves or repurposes its mission)
- Affiliated under MSO contracts (long-term management services agreements that capture economic value while preserving the nonprofit's tax status)
- Merged with another nonprofit (parent-subsidiary structures that bring scale)
The NY Attorney General's office reviews all nonprofit healthcare transactions to ensure mission alignment and proper handling of charitable assets. This is added complexity but not a barrier.
What to do in the next 12 months to maximize sale price
For Article 31 owner-operators contemplating a sale 12–24 months out:
- Apply for or maintain CCBHC certification. CCBHC status is highly valued by buyers because it locks in higher reimbursement rates and signals operational sophistication.
- Stabilize clinician headcount. Buyers diligence clinician retention metrics carefully. A 20% improvement in retention can lift your multiple by 1–2 turns.
- Diversify payor mix. Shift toward managed-care contracts (away from straight Medicaid FFS). Add commercial payor contracts where possible.
- Document everything. Clinical protocols, intake workflows, billing procedures, OMH compliance documentation, telehealth policies. The cleaner your operational documentation, the smoother diligence.
- Resolve any open OMH issues. Any unresolved Plan of Correction (POC) or open survey deficiency is a multiple-compressor. Close them out before going to market.
- Build the financial story. Three years of clean P&Ls, year-over-year clinician productivity, EHR-derived clinical metrics. Healthcare-specialist accounting firms (BakerTilly, EisnerAmper, MGO) can help prepare a Quality of Earnings (QofE) report buyers will trust.
- Build a transition narrative. Buyers value 12–24 month seller transition commitments. Plan yours now — what specific role will you play during transition? What's your hand-off plan for patients and staff?
Free Article 31 valuation
We provide free, confidential valuations for owner-operators of NY Article 31 / MHOTRS clinics. Three-week turnaround. No obligation to sell. No follow-up if there's no fit.
We are currently representing a tri-state healthcare-experienced buyer with an active mandate for Article 31 platform acquisitions in the $5–15M+ range, with a strong preference for 2–4 site behavioral health platforms in NY metro. If your timing fits, the conversation is worth having.
To start: call 201-400-9827 or email steven@nexusbridgebrokers.com.
Frequently Asked Questions
What's the difference between Article 31 and Article 32?
Article 31 of NY Mental Hygiene Law authorizes OMH-licensed mental health programs. Article 32 authorizes the Office of Addiction Services and Supports (OASAS) for substance use disorder programs. Many facilities have dual licensure (treating co-occurring disorders), and dual-licensed clinics are highly valued by acquirers.
How long does it take to sell an Article 31 clinic?
Typically 6–10 months from LOI to close. OMH license transfer is 4–7 months. Material Transaction notice is 30 days. Medicaid managed-care reassignment is 60–120 days. These run in parallel.
Can a non-physician own an Article 31 clinic?
Yes — Article 31 clinics can be owned by non-physicians (or non-physician entities) through OMH's character and competence review. This is a meaningful difference from Article 28, which is more restrictive. Non-physician ownership of Article 31 clinics is common, especially for nonprofit and PE-backed operators.
What if my clinic is licensed by both OMH (Article 31) and DOH (Article 28)?
Some clinics carry dual licensure. The transfer process must satisfy both regulators, which can extend the timeline by 2–4 months. Dual-licensed clinics often command premium valuations because of the operational complexity buyers acquire.
Do I have to sell to a buyer my staff and patients will accept?
Practically, yes. The OMH license transfer process gives OMH and the public 30+ days to comment on the buyer's character and competence. A buyer with a poor track record will face regulatory friction. Most sellers therefore choose buyers committed to operational continuity rather than the highest absolute price.
Steve Reese is the founder of Nexus Bridge Brokers, a tri-state business brokerage focused on healthcare and franchise route transactions in New York, New Jersey, and Connecticut. Direct: 201-400-9827 | steven@nexusbridgebrokers.com
This article is for general information only and is not legal, tax, or investment advice. Any acquisition or sale of an Article 31 facility must be coordinated with qualified healthcare regulatory counsel and OMH-experienced advisors.
Steve Reese is the founder of Nexus Bridge Brokers, a tri-state business brokerage focused on healthcare and franchise route transactions in New York, New Jersey, and Connecticut. Direct: (201) 400-9827 | steven@nexusbridgebrokers.com
This article is for general information only and is not legal, tax, or investment advice. Any acquisition or sale of a regulated healthcare facility must be coordinated with qualified healthcare regulatory counsel.